{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T04:53:31Z","timestamp":1774500811076,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ahj.2021.10.114","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T10:56:38Z","timestamp":1634813798000},"page":"51-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation \u2013 The NOVA Study"],"prefix":"10.1016","volume":"245","author":[{"given":"Jonathan P.","family":"Piccini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Ahlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Dorian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc A.","family":"Gillinov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Kowey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelo A.","family":"Milano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis P.","family":"Perrault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan S.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan H.","family":"Waldron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5021-0135","authenticated-orcid":false,"given":"Lawrence M.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Bharucha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell F.","family":"Brin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William G.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Benussi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2021.10.114_bib0001","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/j.jvca.2018.09.039","article-title":"Society of Cardiovascular Anesthesiologists\/European Association of Cardiothoracic Anesthetists practice advisory for the management of perioperative atrial fibrillation in patients undergoing cardiac surgery","volume":"33","author":"O'Brien","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.ahj.2021.10.114_bib0002","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/14017430802702291","article-title":"Patients with postoperative atrial fibrillation have a doubled cardiovascular mortality","volume":"43","author":"Ahlsson","year":"2009","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.ahj.2021.10.114_bib0003","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.athoracsur.2014.03.039","article-title":"Postoperative atrial fibrillation significantly increases mortality, hospital readmission, and hospital costs","volume":"98","author":"LaPar","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ahj.2021.10.114_bib0004","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/clc.22230","article-title":"Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: insights from the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry","volume":"37","author":"Steinberg","year":"2014","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ahj.2021.10.114_bib0005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.athoracsur.2009.03.076","article-title":"Additive costs of postoperative complications for isolated coronary artery bypass grafting patients in Virginia","volume":"88","author":"Speir","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ahj.2021.10.114_bib0006","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.amjcard.2013.05.029","article-title":"Comparative effectiveness of pharmacotherapies for prevention of atrial fibrillation following coronary artery bypass surgery","volume":"112","author":"Piccini","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2021.10.114_bib0007","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1001\/jama.294.24.3093","article-title":"Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: a randomized controlled trial","volume":"294","author":"Mitchell","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2021.10.114_bib0008","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJMoa1507750","article-title":"Perioperative rosuvastatin in cardiac surgery","volume":"374","author":"Zheng","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2021.10.114_bib0009","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/CIRCRESAHA.114.303772","article-title":"Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy","volume":"114","author":"Chen","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.ahj.2021.10.114_bib0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/1097-0185(20000801)259:4<353::AID-AR10>3.0.CO;2-R","article-title":"Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart","volume":"259","author":"Pauza","year":"2000","journal-title":"Anat Rec"},{"key":"10.1016\/j.ahj.2021.10.114_bib0011","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.athoracsur.2014.06.044","article-title":"Exploration of theoretical ganglionated plexi ablation technique in atrial fibrillation surgery","volume":"98","author":"Sakamoto","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ahj.2021.10.114_bib0012","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.hrthm.2013.04.016","article-title":"Ganglionated plexus ablation vs linear ablation in patients undergoing pulmonary vein isolation for persistent\/long-standing persistent atrial fibrillation: a randomized comparison","volume":"10","author":"Pokushalov","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ahj.2021.10.114_bib0013","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.jacc.2013.06.053","article-title":"Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial","volume":"62","author":"Katritsis","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.10.114_bib0014","first-page":"177","article-title":"The autonomic nervous system and atrial fibrillation:the roles of pulmonary vein isolation and ganglionated plexi ablation","volume":"2","author":"Scherlag","year":"2009","journal-title":"J Atr Fibrillation"},{"key":"10.1016\/j.ahj.2021.10.114_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacep.2015.01.005","article-title":"The role of the autonomic ganglia in atrial fibrillation","volume":"1","author":"Stavrakis","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.ahj.2021.10.114_bib0016","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jacc.2016.06.036","article-title":"Ganglion Plexus Ablation in Advanced Atrial Fibrillation: The AFACT Study","volume":"68","author":"Driessen","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.10.114_bib0017","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/jama.2019.21187","article-title":"Effect of renal denervation and catheter ablation vs catheter ablation alone on atrial ribrillation recurrence among patients with paroxysmal atrial fibrillation and hypertension: the ERADICATE-AF randomized clinical trial","volume":"323","author":"Steinberg","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2021.10.114_bib0018","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/17460441.2017.1303476","article-title":"Challenges in searching for therapeutics against Botulinum Neurotoxins","volume":"12","author":"Pirazzini","year":"2017","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.ahj.2021.10.114_bib0019","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jacc.2014.04.062","article-title":"Botulinum toxin injection in epicardial fat pads can prevent recurrences of atrial fibrillation after cardiac surgery: results of a randomized pilot study","volume":"64","author":"Pokushalov","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2021.10.114_bib0020","article-title":"Temporary autonomic modulation with botulinum toxin type A to reduce atrial fibrillation after cardiac surgery","author":"Waldron","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ahj.2021.10.114_bib0021","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003309","article-title":"Temporary suppression of cardiac ganglionated plexi leads to long-term suppression of atrial fibrillation: evidence of early autonomic intervention to break the vicious cycle of \"AF Begets AF\"","volume":"5","author":"Lo","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2021.10.114_bib0022","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4070\/kcj.2010.40.8.387","article-title":"Short-term autonomic denervation of the atria using botulinum toxin","volume":"40","author":"Oh","year":"2010","journal-title":"Korean Circ J"},{"key":"10.1016\/j.ahj.2021.10.114_bib0023","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/CIRCEP.111.961854","article-title":"Botulinum toxin injection in epicardial autonomic ganglia temporarily suppresses vagally mediated atrial fibrillation","volume":"4","author":"Oh","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ahj.2021.10.114_bib0024","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/CIRCEP.115.003199","article-title":"Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: one-year follow-up of a randomized pilot study","volume":"8","author":"Pokushalov","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ahj.2021.10.114_bib0025","article-title":"Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: Three-year follow-up of a randomized study","author":"Romanov","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ahj.2021.10.114_bib0026","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870321003665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870321003665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:07:37Z","timestamp":1757570857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870321003665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":26,"alternative-id":["S0002870321003665"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2021.10.114","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation \u2013 The NOVA Study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2021.10.114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}